Safeguards and Pitfalls in Technique Used for Stem Cell Delivery in Children Suffering from Idiopathic Dilated Cardiomyopathy  

作　　者：Aris Lacis Inguna Lubaua Inta Bergmane Eriks Jekabsons Janis Ancans Andis Lacis Andrejs Erglis 

机构地区：[1]Clinic of Pediatric Cardiology and Cardiac Surgery, University Hospital for Children, Riga 1004, L V, Latvia [2]Riga Stradins University, Riga 1007, LV, Latvia [3]Pauls Stradins Clinical University Hospital, Riga 1002, L V, Latvia [4]University of Latvia, Riga 1586, L V, Latvia [5]The Latvian Institute of Cardiology, Riga 1002, L V, Latvia

出　　处：《Journal of US-China Medical Science》2013年第3期71-75,共5页美中医学（英文版）

摘　　要：We report 7 pediatric patients with idiopathic dilated mononuclear cells intramyocardial delivery as a final option cardiomyopathy who underwent autologous bone marrow derived after unsuccessful routine conservative treatment and have real perspective for cardiac transplantation in childhood in our country at new time. For two patients intramyocardial delivery was performed repeatedly 22 and 24 months respectively after first repair. All patients received massive anti-congestive therapy by diuretics, ACE inhibitors, carvedilol, digitalis and aspirin.

关 键 词：Idiopathic dilated cardiomyopathy in children stem cell delivery methods. 

分 类 号：TQ464.7[化学工程—制药化工] TS218[轻工技术与工程—粮食、油脂及植物蛋白工程]